Among the companies with shares expected to actively trade in
Friday's session are Chipotle Mexican Grill Inc. (CMG), Google Inc.
(GOOG) and Cepheid (CPHD).
Chipotle Mexican Grill Inc. (CMG) said its customer traffic
growth has slowed recently, raising the possibility that some
people are trading down to less pricey fast-food restaurants as a
result of the uncertain economy. Shares of Chipotle tumbled 12% to
$354.01 after market hours, as the chain's second-quarter revenue
growth and sales at established restaurants fell below Wall Street
analysts' expectations.
Google Inc.'s (GOOG) said its second-quarter profit jumped 11%
thanks to growing interest in its Internet search business, even as
the prices paid by search advertisers continued to drop. Shares
rose 2.7% to $609.20 after hours as Google's report topped many
Wall Street estimates.
Cepheid's (CPHD) second-quarter earnings fell 38% as the maker
of biological testing systems was hurt by higher costs that masked
strong revenue growth. The company also lowered its full-year
earnings estimates. Shares sank 20% to $34.90 after hours.
Advanced Micro Devices Inc. (AMD) reported dismal second-quarter
results and said the weakness would continue into the current
period as the chip maker is hurt by softening consumer demand for
PCs, particularly in China and Europe. The company also forecast
third-quarter revenue below analyst expectations. Shares were off
3.3% to $4.70 after hours.
Align Technology Inc.'s (ALGN) second-quarter earnings more than
doubled as the maker of Invisalign braces saw continued strength in
shipments and revenue. However, the company issued a downbeat
outlook for the current quarter. Shares were off 3% to $30.75 after
hours Thursday.
Freescale Semiconductor Ltd.'s (FSL) second-quarter loss
narrowed as the chip maker strengthened its margins and saw fewer
charges, masking a drop in revenue. Shares dropped 12% in
after-hours trading to $9.01 as the company projected
current-quarter sales below analysts' expectations.
Intuitive Surgical Inc.'s (ISRG) second-quarter earnings rose
32% behind continued strong sales growth for its surgical robots,
but the company also cautioned that it's seeing a decline in
domestic prostate-cancer surgeries. Shares were off 4.2% to $521.50
after hours.
Sustained growth of Microsoft Corp.'s (MSFT) core Office and
enterprise software businesses cheered investors even as the
software giant swung to a fiscal fourth-quarter loss--its first
quarterly loss in at least 20 years--after a write-down and
increase in deferred revenue related to a Windows 8 upgrade
promotion. Shares were up 2.1% to $31.32 as adjusted earnings
topped analyst expectations.
SanDisk Corp.'s (SNDK) second-quarter earnings plummeted as the
flash memory maker saw much weaker sales and profit margins, due to
soft demand for the company's memory chips from makers of mobile
devices. But SanDisk's results were not as bad as some analysts had
feared, sending shares up 11% to $39 after hours.
Staar Surgical Co. (STAA) projected second-quarter revenue below
analyst expectations, noting sales of its Visian ICL lens grew less
than anticipated in Asia Pacific and Europe. Shares sank 7.3% to
$7.49 after hours.
SunCoke Energy Inc. (SXC) said its board has approved the
formation of a master limited partnership, which will hold a
portion of its interests in coke-making facilities in Ohio. Shares
were up 8.5% to $16.30 after hours.
Swift Transportation Co.'s (SWFT) net profit jumped 72% as the
trucking company saw revenue rise and it benefited from lower fuel
prices. Adjusted earnings topped analyst expectations. Shares rose
3.6% to $8.25 after hours.
Rambus Inc.'s (RMBS) second-quarter loss widened as the
technology licenser saw a decline in its revenue from royalties and
contracts. Shares sank 10% to $4.71 in after-hours trading.
Watchlist:
Avon Products Inc.'s (AVP) general counsel and chief compliance
officer, Kim Rucker, will leave the company to take an executive
position at Kraft Foods Inc. (KFT), the companies said.
Bristol-Myers Squibb Co. (BMY) said a Phase 3 trial of its drug,
brivanib, as a first-line treatment in patients with liver cancer
didn't meet its primary survival objective.
Cubist Pharmaceuticals Inc. (CBST) swung to a profit in the
second quarter on a year-earlier contingent consideration charge,
as the biopharmaceutical company continued to post strong sales
growth.
Cytec Industries Inc.'s (CYT) second-quarter earnings rose 1.7%
as the specialty chemicals and materials company saw strong
performance in its engineering materials and in-process separation
segments. The company boosted its adjusted earnings guidance for
the year.
Dole Food Co.'s (DOLE) second-quarter earnings fell 21% as the
fruit-and-vegetable producer saw lower fresh fruit revenue, though
sales of fresh vegetables and packaged foods improved.
WesBanco Inc. (WSBC) said it will acquire Fidelity Bancorp. Inc.
(FSBI) in a deal valued at $70.8 million that expands the bank
holding company's presence in the Pittsburgh market.
Huron Consulting Group Inc. (HURN) said it paid a $1 million
penalty as it settled allegations by the Securities and Exchange
Commission that it violated record-keeping provisions.
Communications-technology company IDT Corp. (IDT) said it plans
to spin off its patent and licensing business, saying the
separation is the best way to maximize value in the unit's
portfolio.
Fitch Ratings lowered its outlook on Ingram Micro Inc. (IM) to
negative from stable, saying the supply-chain-services provider's
planned acquisition of Brightpoint Inc. (CELL) carries severe
financial and operational risks.
Lattice Semiconductor Corp. (LSCC) swung to a second-quarter
loss as the chip maker's sales declined and its margins
weakened.
NCR Corp. (NCR) continued to benefit from ATM improvements at
U.S. regional banks and its own strengthening margin profile from
increasing software business, as second-quarter earnings more than
doubled.
A U.S. judge has upheld the validity of patents covering Pfizer
Inc.'s (PFE) blockbuster pain drug Lyrica, preserving market U.S.
exclusivity for one of the company's best-selling drugs through
2018.
Fitch Ratings upgraded its ratings on Smithfield Foods Inc.
(SFD) one notch closer to investment grade, noting the pork
producer's credit profile has improved following a refinancing
transaction it unveiled earlier this week.
-Write to Nathalie Tadena at nathalie.tadena@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires